Dr. Jeffrey D. Brady, MD

Dr. Brady practices at AdventHealth Surgery Center Mills Park in Orlando, Florida.

Dr. Brady's NPI, 1932195617, was assigned on September 27, 2005. Dr. Brady graduated from SUNY Upstate Medical University in 1992. Dr. Brady holds Florida license ME79788.

Dr. Brady's primary practice is AdventHealth Surgery Center Mills Park, at 1812 N Mills Ave Ste 210, Orlando, FL 32803. The practice phone is (407) 420-0100.

Dr. Brady's primary practice is AdventHealth Surgery Center Mills Park in Orlando, Florida. Dr. Brady is also affiliated with AdventHealth Orlando. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Brady to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brady practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Brady's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Brady is board certified in urology by the American Board of Urology. Dmand AI has Dr. Brady's licenses on file in 2 states: Florida and Virginia.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease, prostate cancer and testicular dysfunction among the conditions Dr. Brady treats.

CMS data shows 811 Medicare services from Dr. Brady across 16 procedure codes in 2024, for 379 Medicare patients. Medicare paid $92,445 for them.

CMS counts 379 Medicare patients who saw Dr. Brady in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brady's median patient age at 71, with 5% women.

In 2024, Dr. Brady wrote 1,072 Medicare Part D claims for 315 patients. 93% of them were for generic drugs. CMS names the drug for 983 of them, across 24 drugs with 11 or more claims each, at $58,748 in total drug cost. In 2023, CMS named 726 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Brady for performance year 2024, reported as part of a group. Dr. Brady accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brady as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Brady, published from 2017 to 2018. 2017 was the busiest year, with 2. Dr. Brady's most frequent co-authors are Joshua Alan Broghammer, MD, Martin Simon Gross, MD and Leroy A. Jones, MD.

CMS Open Payments shows 410 general payments to Dr. Brady from 25 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Boston Scientific Corporation paid the most, $148,194.

Dmand AI lists 3 awards for Dr. Brady, most recently Checkbook Top Doc in 2011.

Dr. Brady graduated from SUNY Upstate Medical University in 1992. Dr. Brady is a member of ACS.

Dr. Brady is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.